Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials
Vitor Martins de Freitas Amorim, Eduardo Pereira Soares, Anielle Salviano de Almeida Ferrari, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 844-844
Open Access | Times Cited: 5
Harnessing Viral Internal Proteins to Combat Flu and Beyond
Hershna Patel, Andreas Kukol
Virology (2025), pp. 110414-110414
Closed Access
The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivo
Michael H. J. Rhodin, Archie C. Reyes, Anand Balakrishnan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Revealing SARS-CoV-2 Mpro Mutation Cold and Hot Spots: Dynamic Residue Network Analysis Meets Machine Learning
Victor Barozi, Shrestha Chakraborty, S. Govender, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3800-3816
Open Access | Times Cited: 3
3-Chymotrypsin-like Protease (3CLpro): Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials
Vitor Martins de Freitas Amorim, Eduardo Pereira Soares, Anielle Salviano de Almeida Ferrari, et al.
(2024)
Open Access | Times Cited: 2
Mechanistic Insights into Targeting SARS-CoV-2 Papain-like Protease in the Evolution and Management of COVID-19
Nonjabulo Ntombikhona Magwaza, Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, et al.
BioChem (2024) Vol. 4, Iss. 3, pp. 268-299
Open Access | Times Cited: 2
Nanotechnology Platform for Advancing Vaccine Development against the COVID-19 Virus
Nusrat Chowdhury, Anup K. Kundu
Diseases (2023) Vol. 11, Iss. 4, pp. 177-177
Open Access | Times Cited: 4
The emerging role of SARS-CoV-2 non-structural protein 1 (nsp1) in epigenetic regulation of host gene expression
Konstantin I. Ivanov, Haibin Yang, Ruixue Sun, et al.
FEMS Microbiology Reviews (2024) Vol. 48, Iss. 5
Open Access | Times Cited: 1
Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Bio-Logical and Pharmacological Profiling
Nadine Álvarez, Gregory C. Adam, John A. Howe, et al.
(2024)
Open Access | Times Cited: 1
Discovery of novel quinoline papain-like protease inhibitors for COVID-19 through topology constrained molecular generative model
Jinsai Shang, Ting Ran, Yongzhi Lu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Inhibition of the SARS-CoV-2 Non-structural Protein 5 (NSP5) Protease by Nitrosocarbonyl-Bases Small Molecules
Marco Leusciatti, Beatrice Macchi, Francesca Marino‐Merlo, et al.
ACS Omega (2024) Vol. 9, Iss. 40, pp. 41599-41615
Open Access
Amino acid T25 in the substrate-binding domain of SARS-CoV-2 nsp5 is involved in viral replication in the mouse lung
Yoshiro Sugiura, Kenta Shimizu, Tatsuki Takahashi, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0312800-e0312800
Open Access
Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological Profiling
Nadine Álvarez, Gregory C. Adam, John A. Howe, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1158-1158
Open Access
Novel Compounds for Preventing SARS-CoV-2 Viral Replication and Treating COVID-19
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 9, pp. 1150-1151
Closed Access
Engineered Therapeutic Antibody Against SARS-CoV-2
Monrat Chulanetra
Current Clinical Microbiology Reports (2023) Vol. 10, Iss. 4, pp. 222-235
Closed Access
Page 1

Scroll to top